Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    1(50%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1
    1
    50%
    Phase 2
    1
    50%

    Phase Distribution

    1

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 1Safety & dosage
    1(50.0%)
    Phase 2Efficacy & side effects
    1(50.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Completed(1)

    Detailed Status

    Active, not recruiting1
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 11 (50.0%)
    Phase 21 (50.0%)

    Trials by Status

    active_not_recruiting150%
    completed150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    active_not_recruitingphase_2

    Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

    NCT05570058
    completedphase_1

    A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

    NCT04931147

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT05570058Phase 2

    Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

    Active Not Recruiting
    NCT04931147Phase 1

    A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2